Hua Han Health Industry : UPDATE ON RESUMPTION PROGRESS

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Hua Han Health Industry Holdings Limited

華瀚健康產業控股有限公司

(Provisional Liquidators Appointed)

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 587)

UPDATE ON RESUMPTION PROGRESS

This announcement is made by Hua Han Health Industry Holdings Limited ("Company"), together with its subsidiaries ("Group") pursuant to the Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) ("SFO") and Rule 13.09 of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited ("Listing Rules").

Reference is made to (i) the announcements of the Company dated 1 August 2018, 21 September 2018 and 9 November 2018 in relation to the Company's update announcements on resumption progress; (ii) the announcement of the Company dated 3 September 2019 in relation to the appointment of the Provisional Liquidators; and (iii) the announcement of the Company dated 3 September 2019 in relation to the resignation of the former directors of the Company (together "Announcements"). Capitalised items defined in the Announcements have the same meaning in this announcement.

As described in the Company's announcement dated 1 August 2018, the Stock Exchange may cancel the Company's listing under Rule 6.01A(2)(b)(ii) of the Listing Rules if the Company fails to resume trading in its shares on or before 31 July 2019. The Stock Exchange is now entitled to cancel the Company's listing.

On 28 August 2019, the Stock Exchange issued a letter to the Provisional Liquidators stating that, after consultation with the Securities and Futures Commission, the Stock Exchange confirms that it will withhold exercising its right to cancel the listing of the Company under Rule 6.01A(2)(b)(ii) of the Listing Rules for three months, until 31 October 2019.

The Stock Exchange indicated that, for the avoidance of doubt, its confirmation is without prejudice to the Stock Exchange exercising its right under Rule 6.01A of the Listing Rules immediately after the three-month period expires. The Stock Exchange also reserves all its rights under the Listing Rules.

Trading in the shares of the Company has been suspended since 27 September 2016 and will remain suspended until further notice.

For and on behalf of

Hua Han Health Industry Holdings Limited

(Provisional Liquidators Appointed)

Chan Ho Yin Michael

and

Chi Lai Man Jocelyn

Joint and Several Provisional Liquidators

Hong Kong, 5 September 2019

As at the date of this announcement, the Board comprises Professor Lin Shu Guang as independent non-executive Director.